Navigation Links
CenterWatch to Introduce Key Findings from Surveys on Physician Referrals to Clinical Trials and Clinical Trial Volunteer Experiences at DIA Meeting
Date:6/18/2009

CenterWatch will present never-before released results from two annual surveys at the upcoming DIA Meeting in San Diego, Calif.

Boston, Mass. (PRWEB) June 18, 2009 -- CenterWatch, a global source for clinical trials information, will present never-before released results from two annual surveys aimed at better understanding physician referrals to clinical trials and study volunteer experiences at DIA's 45th Annual Meeting, June 22-24, 2009, in San Diego, Calif.

CenterWatch's Director of Market Research, Mary Jo Lamberti, Ph.D., will present analysis of 250 physician responses worldwide focusing on factors surrounding physicians' comfort level with referring patients into trials. Her findings will include concerns about trial location, accessibility of a trial for a patient, and general knowledge about a patient's particular disease.

From the volunteer viewpoint, Paul Dewberry, Senior Research Analyst at CenterWatch, will discuss patient experiences in trials across all disease states and will disclose new data on trial participation compensation for study volunteers, which was not previously captured on prior years' surveys. Responses were gathered from approximately 670 volunteers who participated in phase I-IIIb studies, the largest response since the benchmark survey was first released in 2004.

"This year we received more volunteer responses than any other. Additionally, the responses to open-ended questions were superior in quality," Lamberti said. "Patients were more willing to give detailed information which has resulted in much better data and subsequent analysis."

For more information on this presentation and other CenterWatch speaking engagements, visit http://www.centerwatch.com/about-centerwatch/events/index.htm.

About Mary Jo Lamberti, Ph.D.
Mary Jo Lamberti, Ph.D. is the editor of the CenterWatch sourcebook, State of the Clinical Trials Industry and has extensive experience conducting research and evaluation in both academia and in the clinical trials industry. She is a frequent speaker at industry conferences and has published articles in several trade magazines. Dr. Lamberti holds a B.A. from Wellesley College and a Ph.D. from Boston University.

About CenterWatch
Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for both professionals and patients. We provide proprietary data and information about clinical trials through a variety of newsletters, books, databases, and information services used by pharmaceutical and biotechnology companies, CROs, SMOs, and investigative sites involved in the management and conduct of clinical trials. CenterWatch was also the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates. Today, we have one of the largest databases of clinical trials actively seeking patients on the Internet.

###

Read the full story at http://www.prweb.com/releases/2009/06/prweb2541524.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Jobson Medical Information LLC Acquires CenterWatch and New England IRB From Thomson Healthcare
2. HealthFrontier Introduces New Innovation in Web-Based Remote Health Monitoring Technology
3. Texas Institute for Surgery at Presbyterian Hospital of Dallas Introduces the First Wireless OR in DFW
4. Noteworthy Medical Systems Introduces NetPay(TM)
5. Language Technologies Introduces ReadSmart Edition Apps(TM) for the iPhone(TM) and iPod(R) Touch; Unique Apps Improve Ergonomics of Reading while Retaining Look and Design of Print Books
6. CEP America Introduces ER Forum Blog
7. High Activity, Plant Based Diamine Oxidase Enzyme Introduced by Bio-Research Products
8. Autism Family Foundation Introduces The Robert J. Keegan Family Center for Autism
9. Clinical Innovations Introduces New Circumcision Device
10. TOPAZ Technologies Introduces Biosafety Software Solution
11. BellaDerm(TM), a Unique Human Skin Tissue Implant for Facial and Body Contouring, is Introduced by MTF
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... ... January 16, 2017 , ... Etymotic Research, ... GunSport•PRO® and EB15•LE® electronic earplugs at the NSSF SHOT Show on January 17-20, ... The SHOT Show is the shooting, hunting and outdoor trade show and conference ...
(Date:1/16/2017)... ... 16, 2017 , ... As New York’s fastest growing ophthalmic ... to their medical staff, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief ... division of SightMD. Dr. Giamos will practice primarily out of SightMD’s Riverhead, Southampton, ...
(Date:1/16/2017)... ... ... are well-aware of the following facts at present:, Flu and ... no effect on keeping this particularly bad strain of the flu away , ... sniffling , These facts are well-known among the team at Woodard! About ...
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... One thing ... only to treat, but to test for, as well. The money spent screening for ... year.(1) Doctors in the U.S. screen patients for cancer more than in any other ...
(Date:1/15/2017)... ... , ... In this role, Courtney will be responsible for developing new business ... friendly mark. This certification program was created by ASL and the nonprofit Asthma and ... suitable for the 60+ million people living in the U.S. with asthma and allergies. ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... , January 17, 2017 ... to potentially earn millions in revenue with the planned ... massive numbers of strokes with a simple test that ... Companies with latest developments in the markets today include: ... (NYSE: AZN ), Cancer Genetics, Inc. (NASDAQ: ...
(Date:1/17/2017)... 17, 2017 Catherine ... http://www.touchneurology.com/articles/tailored-temperature-management-neurocritical-care ...      (Logo: ... European Neurological Review , ... Amey reports that despite standard care, temperatures ...
(Date:1/17/2017)... 17, 2017  The pioneer in no-touch UV disinfection has ... Tru-D SmartUVC , short for "total room ultraviolet disinfection," was ... Terminal Room-Disinfection (BETR-D) study which was recently published in ... that Tru-D can cut transmission of four major superbugs by ... to market in 2007, we have been committed to innovation ...
Breaking Medicine Technology: